Preclinical development of novel humanised ROR1 targeting chimeric antigen receptor T cells and bispecific T-cell engagers
The Lancet (British edition), 2017-02, Vol.389, p.S40-S40 [Peer Reviewed Journal]Elsevier Ltd ;2017 Elsevier Ltd ;Copyright Elsevier Limited Feb 23, 2017 ;ISSN: 0140-6736 ;EISSN: 1474-547X ;DOI: 10.1016/S0140-6736(17)30436-1 ;CODEN: LANCAO
Full text available